Parenteral Nutrition Trace Element Product Shortage Considerations

The document from ASPEN provided guidelines for managing parenteral nutrition (PN) trace element shortages, emphasizing the importance of assessing each patient's need for PN and using oral or enteral supplements when possible. It highlighted the lower bioavailability and lack of FDA regulation of oral supplements compared to intravenous (IV) administration. The document advised reserving IV trace elements for patients solely dependent on PN and recommended strategies for rationing and substituting trace elements during shortages. It also stressed the importance of monitoring for deficiencies, consulting pharmacists, and adhering to regulatory guidelines to ensure patient safety and fair allocation of resources.